SCHEMBL19306188

SCHEMBL19306188

CCOC(=O)c1ccc([N+](=O)[O-])c(C)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.54
RAB9A P51151 4/20 0.49
GAA P10253 2/20 0.49
KMT2A Q03164 2/20 0.45
MAPT P10636 4/20 0.44
GSTP1 P09211 2/20 0.44
GSTM2 P28161 2/20 0.44
ALDH1A1 P00352 7/20 0.44
NPC1 O15118 2/20 0.44
PKM P14618 1/20 0.44
CRHBP P24387 1/20 0.44
CRHR2 Q13324 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.44
LMNA P02545 2/20 0.44
POLB P06746 2/20 0.44
MITF O75030 2/20 0.44
GALR2 O43603 1/20 0.44
HSP90AA1 P07900 1/20 0.44
HPGD P15428 1/20 0.44
XBP1 P17861 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18188123 0.88 CYP1A2 (0.51) CYP1A2RAB9AGAAKMT2AMAPT
SCHEMBL29924442 0.88 CYP1A2 (0.51) CYP1A2RAB9AGAAKMT2AMAPT
SCHEMBL29210647 0.87 CYP1A2 (0.53) CYP1A2RAB9AGAAKMT2AMAPT
SCHEMBL11388218 0.84 ALDH1A1 (0.42) CYP1A2RAB9AKMT2AMAPTALDH1A1
SCHEMBL16931199 0.84 CYP1A2 (0.50) CYP1A2RAB9AGAAKMT2AMAPT
SCHEMBL2255634 0.79 L3MBTL1 (0.50) RAB9AMAPTALDH1A1POLBL3MBTL1
SCHEMBL30494022 0.79 L3MBTL1 (0.50) RAB9AMAPTALDH1A1POLBL3MBTL1
SCHEMBL7227892 0.78 ALDH1A1 (0.52) RAB9AGAAKMT2AMAPTALDH1A1
SCHEMBL11722947 0.78 ALDH1A1 (0.41) MAPTALDH1A1LMNAPOLBL3MBTL1
SCHEMBL1179292 0.77 CYP1A2 (0.65) CYP1A2RAB9AGAAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3426246-B1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF NATIONAL HEALTH RES INST (TW) 2024-05-01 EP disclosed
CN-108883099-B Thiazolidinone compounds and use thereof 石全 2021-09-28 CN disclosed
US-10544113-B2 Thiazolidinone compounds and use thereof NATIONAL HEALTH RESEARCH INSTITUTE (TW) 2020-01-28 US disclosed
US-10544113-B2 Thiazolidinone compounds and use thereof NATIONAL HEALTH RESEARCH INSTITUTE (TW) 2020-01-28 US disclosed
EP-3426246-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF National Health Research Institutes (TW) 2019-01-16 EP disclosed
WO-2017155910-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2017-09-14 WO disclosed
WO-2017155910-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF NATIONAL HEALTH RESEARCH INSTITUTES (TW) 2017-09-14 WO disclosed
US-20170253569-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-09-07 US disclosed
US-20170253569-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF REGENTS OF THE UNIVERSITY OF MINNESOTA 2017-09-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10544113-B2 Thiazolidinone compounds and use thereof OPRL1, OPRD1, OPRK1 CYP1A2 148/4885RAB9A 2807/4885GAA 1589/4885
US-20170253569-A1 THIAZOLIDINONE COMPOUNDS AND USE THEREOF OPRL1, OPRD1, OPRK1 CYP1A2 148/4885RAB9A 2807/4885GAA 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.